Quebec Launches $21M Personalized Medicine Partnership | GenomeWeb

NEW YORK (GenomeWeb News) – Quebec's government will provide C$10 million (US$9.9 million) over four years to launch a new personalized cancer medicine collaboration between private and public partners that will aim to integrate biomarkers into cancer care and reduce treatment costs.

The new Personalized Medicine Partnership for Cancer also will raise C$11.1 million from private-sector partners, and it will be led by the Montreal-based protein biomarker developer Caprion Proteome, according to the partners in the effort.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: phosphoproteomic patterns in prostate cancer, effect of gene expression on fitness in yeast, and more.

Scripps Research Institute investigators peer back at the RNA world.

Being born premature shouldn't mean infants with high blood sugar levels don't undergo genetic testing for neonatal diabetes, a study in Pediatrics says.

In PNAS this week: chromosome instability in S. cerevisiae, structural differences and sequence divergence in rice, and more.